--- title: "Cross-Border Ambitions and Domestic Drag: The Structural Reshaping of HK Equities" type: "News" locale: "en" url: "https://longbridge.com/en/news/293729704.md" description: "Examining nine Hong Kong-listed equities reveals a stark divergence. Amid sluggish domestic demand and shifting monetary cycles, companies are increasingly leaning on international expansion and sector consolidation to buffer downside risks to earnings." datetime: "2026-07-24T09:12:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293729704.md) - [en](https://longbridge.com/en/news/293729704.md) - [zh-HK](https://longbridge.com/zh-HK/news/293729704.md) generator: "portal-rs" --- # Cross-Border Ambitions and Domestic Drag: The Structural Reshaping of HK Equities Against the backdrop of domestic rebalancing and the persistent reshaping of global supply chains, a diverse swath of Hong Kong equities—ranging from green energy to consumer staples—has sent its strongest signal yet that cross-border expansion and industry consolidation are now imperative to offset domestic margin compression. The core tension traversing this cohort centers on a fundamental divergence: whether these mid-cap and sector-specific players can sufficiently restructure their balance sheets before heightened trade barriers and currency fluctuations choke off potential upside. ### Guoxia Technology (2655.HK) & Ruifeng Power (0527.HK) Demonstrating the aggressive push into cross-border markets, energy storage provider **Guoxia Technology (2655.HK)** has sought to capitalize on international green-tech flows. Following a staggering **663%** surge in 1H 2025 revenue to **RMB 691M**, the company recently struck a strategic partnership with Rocmore to penetrate European markets, a move that prompted a notable intraday rally. In a similar vein of capital shoring, **Ruifeng Power (0527.HK)** completed a placement in July 2026 to raise approximately **HKD 54.5M** to fund ongoing wind and energy storage operations. ### Ju Teng International (3336.HK), China CITIC Bank (0998.HK) & Great Wall Terroir (8315.HK) Vulnerabilities tied to global trade shifts remain stark. Casing manufacturer **Ju Teng International (3336.HK)** issued a profit warning for 1H 2026, projecting losses between **HKD 750M and HKD 850M**. The deterioration is partly fueled by mounting forex losses and shrinking capacity utilization, compounding the uncertainty surrounding its pending acquisition by Lens Technology, which remains mired in anti-monopoly reviews. On a broader systemic level, **China CITIC Bank (0998.HK)** and investment holding firm **Great Wall Terroir (8315.HK)** continue to navigate a constrained liquidity environment, operating under the shadow of the PBOC's cautious monetary easing and shifting net interest margins. ### Dekang Group (2419.HK) & Helens (9869.HK) Downside risks to domestic consumption continue to materialize. **Dekang Group (2419.HK)** anticipates a severe net loss of **RMB 1.2B to RMB 1.4B** for 1H 2026, driven by a protracted slump in the swine market, even as June 2026 data showed a modest **2.23%** sequential uptick in pork prices. Meanwhile, the bar chain operator **Helens (9869.HK)** faces unprecedented headwinds after a Beijing court invalidated three of its core domestic trademarks, forcing a potential rebranding effort amidst cutthroat consumer price wars. ### Huaren Biopharma-B (2396.HK) & China Silver Group (0815.HK) The financing window for pre-revenue biotech and commodity players remains unforgiving. **Huaren Biopharma-B (2396.HK)**, which reported a net loss of **RMB 209M** in 2025, is rebranding to "Qingcheng Innovative Drugs" following a prolonged sell-off that wiped out over 80% of its value since IPO. Conversely, **China Silver Group (0815.HK)** finalized its new share subscription in June 2026, aiming to fortify its capital buffers against the erratic volatility in global precious metal markets. Looking ahead, as global central banks maintain a meeting-by-meeting stance on rate trajectories, the success of these expansion and consolidation maneuvers will hinge heavily on cross-market policy spillovers. Should domestic weakness persist, the structural downside risks for these firms will only deepen heading into the latter half of 2026. *This article does not constitute investment advice.* ### Related Stocks - [02419.HK](https://longbridge.com/en/quote/02419.HK.md) - [02655.HK](https://longbridge.com/en/quote/02655.HK.md) - [08315.HK](https://longbridge.com/en/quote/08315.HK.md) - [03336.HK](https://longbridge.com/en/quote/03336.HK.md) - [02396.HK](https://longbridge.com/en/quote/02396.HK.md) - [09869.HK](https://longbridge.com/en/quote/09869.HK.md) ## Related News & Research - [B&K Corporation Wins Shareholder Backing for Share Circulation, Awards and Governance Changes](https://longbridge.com/en/news/298050310.md) - [Century Plaza Hotel Group publishes 2025/26 annual report](https://longbridge.com/en/news/294507111.md) - [Citic Securities Sticks to Its Buy Rating for Dekon Food And Agriculture Group Class H (2419)](https://longbridge.com/en/news/298083647.md) - [Guoxia Technology’s Interim Profit Soars on Strong Revenue and Margin Gains](https://longbridge.com/en/news/296520987.md) - [Lens Technology offer for Ju Teng awaits PRC, Vietnam antitrust clearances, company says](https://longbridge.com/en/news/295203373.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**